ApoGlyx

ApoGlyx

Biotechnology Research Lund, Skåne Län, Se 5 employees
Employees
5
Contacts
2
Emails
2

ApoGlyx Overview

Headquarters
Lund, Skåne Län, Se
Website
apoglyx.com
Industry
Biotechnology Research
Employees
5
Founded
2015
Funding
697.1K
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ApoGlyx

Apoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy for sepsis, and further indications, based on inhibition of Aquaporin-9. Apoglyx was founded based on research from Aarhus University (DK), Aalborg University (DK), and Lund University (S).

ApoGlyx Contact Details

People in AeroLeads
3
With contact data
2
Email contacts
2
66.7% coverage

ApoGlyx Org Chart

Sample employees and titles
Name Title Contact
Filippo Perego Doctoral Researcher at Apoglyx Ab
View
Preben Bruun-Nyzell Chief Executive Officer at 2a Pharma
Email
Helen Pettersson Investment Manager På Almi Invest Syd
Email

Employees by Management Level

Executive 1 profile
Manager 1 profile
Individual contributor 1 profile

Compare Similar Companies to ApoGlyx